ADT
23
-10
AMT
55
-3
TRV
62
-2
AMZN
60
2
CA
40
4
WAT
52
3
MTCH
48
4
DAL
66
2
ADSK
67
2
T
54
-6
IR
77
8
CVX
40
2
WM
65
3
HBAN
48
3
SLG
64
-2
WFC
61
3
EMC
56
11
MUR
52
3
VFC
53
-4
AVB
67
2
ADT
23
-10
AMT
55
-3
TRV
62
-2
AMZN
60
2
CA
40
4
WAT
52
3
MTCH
48
4
DAL
66
2
ADSK
67
2
T
54
-6
IR
77
8
CVX
40
2
WM
65
3
HBAN
48
3
SLG
64
-2
WFC
61
3
EMC
56
11
MUR
52
3
VFC
53
-4
AVB
67
2
Financhill
Back

Edwards Lifesciences Quote, Financials, Valuation and Earnings

"EarnPhone": The Investment Hidden in Plain Sight

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
15

EW
Edwards Lifesciences

Last Price:
66.77
Seasonality Move:
2.86%

7 Day Trial

ALL ACCESS PASS

$ 7

32,481% Growth? Meet Mode Mobile's "EarnPhone"

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Edwards Lifesciences Price Quote

$66.77
-0.49 (-0.73%)
(Updated: September 20, 2024 at 6:55 PM ET)

Edwards Lifesciences Key Stats

Sell
15
Edwards Lifesciences (EW) is a Sell
Day range:
$67.14 - $69.08
52-week range:
$58.93 - $96.12
Dividend yield:
0%
P/E ratio:
29.24
P/S ratio:
6.80
P/B ratio:
5.45%
Volume:
7.1M
Avg. volume:
6.3M
1-year change:
-7.89%
Market cap:
$40.5B
Revenue:
$6B
EPS:
$2.43

How Much Does Edwards Lifesciences Make?

Is Edwards Lifesciences Growing As A Company?

  • What Is Edwards Lifesciences's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.07%
  • What Is Edwards Lifesciences's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.22%

Edwards Lifesciences Stock Price Performance

What Is Edwards Lifesciences 52-Week High & Low?

Edwards Lifesciences Price To Free Cash Flow

Is It Risky To Buy Edwards Lifesciences?

Is Edwards Lifesciences Cash Flow Positive?

  • What Is EW Cash Flow From Operations?
    Cash flow from operations (TTM) is $866.1M
  • What Is Edwards Lifesciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$591.4M
  • What Is Edwards Lifesciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $291M

Edwards Lifesciences Return On Invested Capital

  • Is Management Doing A Good Job?
    EW return on invested capital is 19.6%
  • What Is Edwards Lifesciences Return On Assets?
    ROA measures how assets are converting to revenues and is 15.48%
  • What Is EW Return On Equity?
    ROE is a measure of profitability and is 21.3%

Edwards Lifesciences Earnings Date & Stock Price

Edwards Lifesciences Competitors

  • Who Are Edwards Lifesciences's Competitors?
    Below is a list of companies who compete with Edwards Lifesciences or are related in some way:
    • Becton Dickinson & Co (BDX)
    • Boston Scientific Corp (BSX)
    • NeuroOne Medical Technologies Corp (NMTC)
    • Nutriband Inc (NTRB)
    • SINTX Technologies Inc (SINT)

Edwards Lifesciences Dividend Yield

Edwards Lifesciences Analyst Estimates

YoY Growth Past Surprise
EPS: 22% 0.88%
Revenue: 6.98% -1.26%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 17
Sell Recommendations: 0
Price Target: 78.86
Upside from Last Price: 17.25%

Major Shareholders

  • How many EW shares are owned by institutional investors?
    718.6M EW shares are owned by institutional investors
  • How many EW shares are owned by insiders?
    1.8M EW shares are owned by insiders